vs
BICYCLE THERAPEUTICS PLC（BCYC）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是BICYCLE THERAPEUTICS PLC的1.0倍（$50.3M vs $48.0M），READING INTERNATIONAL INC净利率更高（-5.1% vs -42.0%，领先36.9%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs -14.2%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-19.9M），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs 5.6%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
BCYC vs RDI — 直观对比
营收规模更大
RDI
是对方的1.0倍
$48.0M
营收增速更快
BCYC
高出1207.5%
-14.2%
净利率更高
RDI
高出36.9%
-42.0%
自由现金流更多
RDI
多$24.0M
$-19.9M
两年增速更快
BCYC
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $50.3M |
| 净利润 | $-20.2M | $-2.6M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | -1.9% |
| 净利率 | -42.0% | -5.1% |
| 营收同比 | 1193.3% | -14.2% |
| 净利润同比 | 61.1% | -14.5% |
| 每股收益（稀释后） | $-0.29 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCRDI
| Q4 25 | $48.0M | $50.3M | ||
| Q3 25 | $11.7M | $52.2M | ||
| Q2 25 | $2.9M | $60.4M | ||
| Q1 25 | $10.0M | $40.2M | ||
| Q4 24 | $3.7M | $58.6M | ||
| Q3 24 | $2.7M | $60.1M | ||
| Q2 24 | $9.4M | $46.8M | ||
| Q1 24 | $19.5M | $45.1M |
净利润BCYCRDI
| Q4 25 | $-20.2M | $-2.6M | ||
| Q3 25 | $-59.1M | $-4.2M | ||
| Q2 25 | $-79.0M | $-2.7M | ||
| Q1 25 | $-60.8M | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-50.8M | $-7.0M | ||
| Q2 24 | $-39.8M | $-12.8M | ||
| Q1 24 | $-26.6M | $-13.2M |
营业利润率BCYCRDI
| Q4 25 | -51.5% | -1.9% | ||
| Q3 25 | -558.6% | -0.6% | ||
| Q2 25 | -2965.8% | 4.8% | ||
| Q1 25 | -703.7% | -17.2% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | -2385.9% | -0.6% | ||
| Q2 24 | -498.3% | -16.4% | ||
| Q1 24 | -162.4% | -16.7% |
净利率BCYCRDI
| Q4 25 | -42.0% | -5.1% | ||
| Q3 25 | -503.7% | -8.0% | ||
| Q2 25 | -2703.8% | -4.4% | ||
| Q1 25 | -608.9% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | -1898.4% | -11.7% | ||
| Q2 24 | -425.3% | -27.4% | ||
| Q1 24 | -136.0% | -29.4% |
每股收益（稀释后）BCYCRDI
| Q4 25 | $-0.29 | $-0.11 | ||
| Q3 25 | $-0.85 | $-0.18 | ||
| Q2 25 | $-1.14 | $-0.12 | ||
| Q1 25 | $-0.88 | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | $-0.74 | $-0.31 | ||
| Q2 24 | $-0.77 | $-0.57 | ||
| Q1 24 | $-0.62 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $610.0M | $-18.2M |
| 总资产 | $717.6M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCRDI
| Q4 25 | $628.1M | $10.5M | ||
| Q3 25 | $648.3M | $8.1M | ||
| Q2 25 | $721.5M | $9.1M | ||
| Q1 25 | $793.0M | $5.9M | ||
| Q4 24 | $879.5M | $12.4M | ||
| Q3 24 | $890.9M | $10.1M | ||
| Q2 24 | $961.4M | $9.3M | ||
| Q1 24 | $457.0M | $7.5M |
总债务BCYCRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCRDI
| Q4 25 | $610.0M | $-18.2M | ||
| Q3 25 | $618.5M | $-12.1M | ||
| Q2 25 | $668.9M | $-7.7M | ||
| Q1 25 | $740.3M | $-8.1M | ||
| Q4 24 | $793.1M | $-4.4M | ||
| Q3 24 | $831.0M | $1.6M | ||
| Q2 24 | $873.8M | $6.5M | ||
| Q1 24 | $356.0M | $18.0M |
总资产BCYCRDI
| Q4 25 | $717.6M | $434.9M | ||
| Q3 25 | $764.0M | $435.2M | ||
| Q2 25 | $832.2M | $438.1M | ||
| Q1 25 | $883.9M | $441.0M | ||
| Q4 24 | $956.9M | $471.0M | ||
| Q3 24 | $996.7M | $495.7M | ||
| Q2 24 | $1.1B | $494.9M | ||
| Q1 24 | $547.1M | $494.9M |
负债/权益比BCYCRDI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $4.1M |
| 自由现金流率自由现金流/营收 | -41.5% | 8.2% |
| 资本支出强度资本支出/营收 | 1.2% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流BCYCRDI
| Q4 25 | $-19.3M | $4.3M | ||
| Q3 25 | $-71.2M | $295.0K | ||
| Q2 25 | $-72.8M | $1.6M | ||
| Q1 25 | $-86.4M | $-7.7M | ||
| Q4 24 | $-164.7M | $8.0M | ||
| Q3 24 | $-39.8M | $1.3M | ||
| Q2 24 | $-44.6M | $-10.4M | ||
| Q1 24 | $-70.9M | $-2.8M |
自由现金流BCYCRDI
| Q4 25 | $-19.9M | $4.1M | ||
| Q3 25 | $-71.8M | $-246.0K | ||
| Q2 25 | $-73.3M | $1.2M | ||
| Q1 25 | $-87.0M | $-8.0M | ||
| Q4 24 | $-166.0M | $7.0M | ||
| Q3 24 | $-40.3M | $-1.1M | ||
| Q2 24 | $-45.0M | $-10.6M | ||
| Q1 24 | $-70.9M | $-4.7M |
自由现金流率BCYCRDI
| Q4 25 | -41.5% | 8.2% | ||
| Q3 25 | -612.3% | -0.5% | ||
| Q2 25 | -2509.7% | 1.9% | ||
| Q1 25 | -871.7% | -19.8% | ||
| Q4 24 | -4475.7% | 12.0% | ||
| Q3 24 | -1504.7% | -1.8% | ||
| Q2 24 | -481.2% | -22.7% | ||
| Q1 24 | -362.9% | -10.4% |
资本支出强度BCYCRDI
| Q4 25 | 1.2% | 0.3% | ||
| Q3 25 | 5.7% | 1.0% | ||
| Q2 25 | 17.1% | 0.6% | ||
| Q1 25 | 6.1% | 0.6% | ||
| Q4 24 | 33.3% | 1.7% | ||
| Q3 24 | 16.3% | 4.0% | ||
| Q2 24 | 4.5% | 0.5% | ||
| Q1 24 | 0.1% | 4.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCYC
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
